Diagnosing Diseases Through The Eye

About this Event

Zilia is a medtech and medical device company that has developed an innovative platform that is capable of non-invasively diagnosing and monitoring a wide range of diseases through the eye.

Zilia Ocular is a hybrid retinal camera that combines imaging and spectroscopy to capture previously unobtainable information, providing key insights to improve health. It is paired with an AI-powered cloud platform, Zilia Zone, for EMR integration, data storage and sharing, advanced analytics, remote patient management and patient reporting.

While Zilia helps eye care professionals gain access to valuable insights, enabling earlier diagnosis, clearer prognosis, and improved treatment strategies for diseases like glaucoma, diabetic retinopathy, and AMD, it also has applications in neurology, pharmacology, cardiology, and more.

Watch the webinar with Zilia CEO, Dr Patrick Sauvageau, to learn more about the opportunity presented by this breakthrough medical device which already has been given 510(k) clearance and been assigned a CPT code.

Hosted by Steven Saltzstein. CEO, Force Family Office

Video On Demand

– Recorded

March 26


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.